Skeletal muscle-specific forkhead box protein-O1 overexpression suppresses atherosclerosis progression in apolipoprotein E-knockout mice

被引:4
|
作者
Shimba, Yuki [1 ,2 ]
Senda, Rena [1 ]
Katayama, Keigo [1 ]
Morita, Akihito [1 ]
Ikeda, Masahiko [3 ]
Kamei, Yasutomi [4 ]
Miura, Shinji [1 ]
机构
[1] Univ Shizuoka, Lab Nutr Biochem, Grad Sch Nutr & Environm Sci, 52-1 Yada, Shizuoka, Shizuoka 4228526, Japan
[2] Japan Soc Promot Sci, 5-3-1 Kojimachi, Tokyo 1020083, Japan
[3] Tokoha Univ, Fac Social & Environm Studies, 6-1 Yayoi Cho, Shizuoka, Shizuoka 4228581, Japan
[4] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Life & Environm Sci, 1-5 Shimogamohangicho, Kyoto, Kyoto 6068522, Japan
关键词
Forkhead box protein-O1; Atherosclerosis; Apolipoprotein E-knockout mouse; Vascular cell adhesion molecule-1; Human umbilical vein endothelial cells;
D O I
10.1016/j.bbrc.2021.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calorie restriction (CR) reportedly prevents atherosclerotic diseases. Furthermore, CR induces forkhead box protein-O1 (FOXO-1) expression in the skeletal muscle, altering the character of the skeletal muscle. We previously reported that the change in skeletal muscle character, induced by the overexpression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha, suppresses atherosclerotic progression in an atherosclerotic apolipoprotein E-knockout (ApoE-KO) mouse model. Thus, we hypothesized that skeletal muscle alternation induced by FOXO-1 may also have an anti-atherosclerotic effect in ApoE-KO mice. In this study, we investigated whether skeletal muscle-specific FOXO-1 overexpression suppresses the progression of atherosclerosis in ApoE-KO mice. We generated ApoE-KO/FOXO-1 mice, in which an ApoE-KO mouse was crossbred with a mouse presenting skeletal muscle-specific FOXO-1 overexpression (FOXO-1Tg). The mice were sacrificed at 20 weeks of age, and atherosclerotic plaque area and protein expression in the plaque were measured. Additionally, we measured the tumor necrosis factor alpha (TNF alpha)-induced mRNA expression in human umbilical vein endothelial cells (HUVECs), using serum collected from the FOXO-1Tg mice. Accordingly, ApoE-KO/FOXO-1 mice showed a 65% reduced atherosclerotic plaque area when compared with the ApoE-KO mice, with concomitantly reduced vascular cell adhesion molecule-1 (VCAM-1) and macrophage infiltration. As compared to serum from wild-type mice, the serum collected from the FOXO-1Tg mice significantly suppressed the mRNA expression of VCAM-1, an atherosclerosis initiation factor, in TNF alpha-treated HUVECs. Therefore, these data suggest that skeletal muscle-specific FOXO-1 overexpression suppresses the progression of atherosclerosis in ApoE-KO mice. In part, the CR-induced anti-atherosclerotic effect could be attributed to FOXO-1 upregulation in the skeletal muscle. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Skeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
    Shimba, Yuki
    Togawa, Hanako
    Senoo, Nanami
    Ikeda, Masahiko
    Miyoshi, Noriyuki
    Morita, Akihito
    Miura, Shinji
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] Skeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
    Yuki Shimba
    Hanako Togawa
    Nanami Senoo
    Masahiko Ikeda
    Noriyuki Miyoshi
    Akihito Morita
    Shinji Miura
    Scientific Reports, 9
  • [3] SKELETAL MUSCLE-SPECIFIC PGC-1α OVEREXPRESSION PREVENTS ATHEROSCLEROSIS IN APOLIPOPROTEIN E-KNOCKOUT MICE
    Shimba, Yuki
    Togawa, Hanako
    Senoo, Nanami
    Ikeda, Masahiko
    Miyoshi, Noriyuki
    Morita, Akihito
    Miura, Shinji
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 17 - 18
  • [4] β-Aminoisobutyric Acid Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
    Shimba, Yuki
    Katayama, Keigo
    Miyoshi, Noriyuki
    Ikeda, Masahiko
    Morita, Akihito
    Miura, Shinji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (06) : 1016 - 1019
  • [5] Chronic Hypoxia Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice
    Daisuke Nakano
    Tetsuya Hayashi
    Naoko Tazawa
    Chika Yamashita
    Sakiko Inamoto
    Nobuaki Okuda
    Tatsuhiko Mori
    Koichi Sohmiya
    Yasushi Kitaura
    Yoshikatsu Okada
    Yasuo Matsumura
    Hypertension Research, 2005, 28 : 837 - 845
  • [6] Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice
    Nakano, D
    Hayashi, T
    Tazawa, N
    Yamashita, C
    Inamoto, S
    Okuda, N
    Mori, T
    Sohmiya, K
    Kitaura, Y
    Okada, Y
    Matsumura, Y
    HYPERTENSION RESEARCH, 2005, 28 (10) : 837 - 845
  • [7] Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice
    Hattori, Yoshiyuki
    Hattori, Sachiko
    Wang, Xi
    Satoh, Hiroko
    Nakanishi, Nobuo
    Kasai, Kikuo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (04) : 865 - 870
  • [8] GENETIC DEFICIENCY IN FUNCTIONAL MMP-10 REDUCES PROGRESSION OF ATHEROSCLEROSIS IN APOLIPOPROTEIN E-KNOCKOUT MICE
    Purroy, A.
    Belzunce, M.
    Orbe, J.
    Barrenetxe, J.
    Paramo, J. A.
    Rodriguez, J. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 9 - 10
  • [9] Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice
    Thomson, David M.
    Hancock, Chad R.
    Evanson, Bradley G.
    Kenney, Steven G.
    Malan, Brandon B.
    Mongillo, Anthony D.
    Brown, Jacob D.
    Hepworth, Squire
    Fillmore, Natasha
    Parcell, Allen C.
    Kooyman, David L.
    Winder, William W.
    JOURNAL OF APPLIED PHYSIOLOGY, 2010, 108 (06) : 1775 - 1785
  • [10] Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice
    Inoue, S
    Egashira, K
    Ni, WH
    Kitamoto, S
    Usui, M
    Otani, K
    Ishibashi, M
    Hiasa, K
    Nishida, K
    Takeshita, A
    CIRCULATION, 2002, 106 (21) : 2700 - 2706